zanubrutinib,ibrutinib
abbvie,janssen,beigene
[' ibru', 'magnolia', 'zanubrutinib', 'lymsm']
congress | #ash22 presents final analysis from the magnolia trial of zanubrutinib in patients with r/r #mzl. the results indicate strong long-term efficacy, indicated by high response rates durable disease control, and a favourable safety profile
#lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm